Drying probiotics is unforgiving. A 5 °C overshoot can drop viable cell counts by 1–2 log — turning a premium culture into a commodity powder.
Three engineering levers matter most for cell viability during drying:
-
Inlet temperature precision (±2 °C), not just setpoint accuracy. A spray dryer running at 170 °C inlet with poor PID tuning will routinely spike to 180+ °C during feed-rate fluctuations, denaturing the cell wall proteins. Look for dryers with multi-zone heating and closed-loop thermal control.
-
Residence time symmetry. Long-tail distribution in a conventional chamber means some particles sit 40–60 seconds, others 8–10. The slow ones die. Pneumatic + cyclone-coupled designs with narrow residence time distributions preserve 10–20% more CFU/g at the same outlet temperature.
-
Outlet temperature as the real KPI. Most operators control inlet — but cell viability correlates almost linearly with outlet (typically 65–80 °C for Lactobacilli, 55–70 °C for Bifidus). Inlet is a process parameter; outlet is the survival parameter.
A secondary trend worth watching: hybrid fluidized-bed + spray approaches for encapsulating probiotics in a starch or protein matrix during the drying step itself. The result is higher viable counts after 12-month shelf storage, fewer carrier excipients, and a single-pass operation that replaces two downstream steps. European CDMOs in the infant formula space are now specifying these integrated lines as default in new RFQs.
The global probiotics market continues to compound at 7–8% annually, and the bottleneck is no longer fermentation capacity — it's downstream drying and stabilization. Procurement teams that treat drying as a commodity line item tend to lose 15–25% of theoretical yield. Treating it as a critical process step — with FAT protocols that include CFU/g testing at multiple feed rates — usually pays for itself within two production batches.
